News
During a live event, Christine Bestvina, MD, discussed trials of KRAS inhibitors plus immunotherapy in patients with ...
New long-term data from the Phase III FLAURA2 trial confirm that Tagrisso combined with chemotherapy delivers a significant overall survival benefit over monotherapy in patients with advanced ...
13hOpinion
The Well News on MSNReleased FDA Files Show Flawed Drug Approval ProcessFor decades, the Food and Drug Administration has been notoriously tight-lipped about why it rejects drugs. It has remained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results